Endo Expands Voluntary Recall of Clonazepam Orally Tablets
19 Nov 2024 //
FDA
Endo Presents Data At American Society Of Podiatric Surgeons
18 Oct 2024 //
PR NEWSWIRE
Endo Announces Seven New Presentations At SMSNA Annual Meeting
17 Oct 2024 //
PR NEWSWIRE
Auxilium`s Biologic Xiaflex (Clostridium) Receives Suppl. Approval in US
11 Oct 2024 //
FDA
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Endo Issues Voluntary Nationwide Recall of Clonazepam Tablets
17 Jul 2024 //
FDA
Endo USA Recalls Mislabeled Clonazepam Tablets Lot 550147301
16 Jul 2024 //
PRESS RELEASE
Endo takes a hands-on approach to new Dupuytren`s contracture ad
10 Jun 2024 //
FIERCE PHARMA
Endo sues FDA over its handling of generic Adrenalin approvals
11 Apr 2024 //
ENDPTS
Opioid Qui Tam False Claims Act Case filed by Young Law Group
29 Feb 2024 //
PR NEWSWIRE
Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
02 Nov 2023 //
PR NEWSWIRE
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection)
12 Jun 2023 //
PR NEWSWIRE
Endo Announces Publication of XIAFLEX Data Analysis in Peer-Reviewed Urology®
05 Jun 2023 //
PR NEWSWIRE
Endo Announces Agreement with MAIA Pharmaceuticals
24 May 2023 //
PR NEWSWIRE
Enforcement Report - Week of April 5, 2023
05 Apr 2023 //
FDA
Endo, Impax Beat Bid for Special Procedures at Antitrust Trial
23 Apr 2022 //
BLOOMBERGLAW
Auxilium Pharms` Biologic Xiaflex Receives Approval in the U.S.
11 Jan 2022 //
FDA
Endo taps bent veggie in first Xiaflex brand campaign for Peyronie`s disease
25 Oct 2021 //
ENDPTS
Labaton Sucharow & F. Kanner London & Millen Announce Pendency of Class Action
07 Oct 2021 //
PRNEWSWIRE
NY Decries `Brazen Gaslighting` By Endo`s Opioid Attys
20 Aug 2021 //
LAW360
Takeda, Endo hit with antitrust suit over pay-for-delay deal
01 Jul 2021 //
FIERCEPHARMA
J&J, AbbVie, Teva and Endo to face first opioid trial since 2019
19 Apr 2021 //
FIERCEPHARMA
Fifth Circuit sides with FTC in major pay-for-delay settlement case
15 Apr 2021 //
ENDPTS
Endo Comments on Entry of Default Liability Judgment in Tennessee
07 Apr 2021 //
PRNEWSWIRE
FTC Makes Double Reverse Payment Case Against Endo And Impax
02 Feb 2021 //
PHARMAINTELLIGENCE
Endo Announces Licensing Agreement for Paladin Labs to Abaloparatide
05 Jan 2021 //
PRNEWSWIRE
Endo Launches Authorized Generic Version of Amitiza® (lubiprostone)
04 Jan 2021 //
PRNEWSWIRE
Endo eliminating 560 positions as its prepares to launch cellulite treatment
07 Dec 2020 //
BIZJOURNALS
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
02 Dec 2020 //
PRNEWSWIRE
Endo cuts 560 staffers to save cash for spring drug launch
06 Nov 2020 //
FIERCE PHARMA
Endo Announces Strategic Actions to Further Position the Company
05 Nov 2020 //
PRNEWSWIRE
BioSpecifics to be Acquired by Endo Pharmaceuticals
20 Oct 2020 //
ENDPTS
Endo Releases First Environmental, Social and Governance Report
06 Oct 2020 //
PRNEWSWIRE
Endo starts manufacturing Novavax`s potential COVID-19 vaccine
25 Sep 2020 //
REUTERS
Endo International plc Announces The Expiration And Final Tender Results
21 Aug 2020 //
PRNEWSWIRE
Investor Says Endo Lied About Role In NY Opioid Crisis
23 Jun 2020 //
LAW360
New York charges Endo with insurance fraud over opioid claims
11 Jun 2020 //
REUTERS
Endo International plc Announces Early Tender Results Of Its Announced
29 May 2020 //
PRNEWSWIRE
Endo to Participate at 2020 RBC Capital Markets Global Healthcare
14 May 2020 //
PRNEWSWIRE
Endo Reports First-Quarter 2020 Financial Results and Provides Update Relating
08 May 2020 //
PRESS RELEASE
COVID-19 tracker: Endo, Sarepta, Alnylam and more
07 May 2020 //
FIERCE PHARMA
Endo touts `flexibility` as opioid deals bankrupt competitors
27 Feb 2020 //
FIERCE PHARMA
Endo Appoints Mark G. Barberio to Board of Directors
19 Feb 2020 //
PR NEWSWIRE
Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate)
28 Jan 2020 //
PR NEWSWIRE
Endo CEO`s departure another C-suite hit at generic industry`s biggest players
07 Nov 2019 //
FIERCE PHARMA
Teva, distributors sidestep Ohio opioid trial with deal: WSJ
21 Oct 2019 //
FIERCE PHARMA
Opioid makers consider participating in Purdue settlement: WSJ
02 Oct 2019 //
FIERCE PHARMA
Drugmakers pursue new plan to wrap opioid suits
30 Sep 2019 //
SEEKINGAPLPHA
Opioid giant Purdue files for bankruptcy to pay for sweeping settlement
17 Sep 2019 //
BIOPHARMADIVE
Opioid defendants push for district judge`s recusal: roundup
16 Sep 2019 //
FIERCE PHARMA
Alex Arfaei trades his analyst`s post for a new role as biotech VC
13 Sep 2019 //
ENDPTS
Endo Announces Execution of Agreement & Release Resolving "Track 1" Opioid Cases
05 Sep 2019 //
PR NEWSWIRE
Endo introduces generic Noxafil DR tablets in US market
04 Sep 2019 //
PHARMABIZ
Endo Launches Authorized Generic Version of Noxafil® (posaconazole) D
03 Sep 2019 //
PR NEWSWIR
State attorneys general dubious about Purdue`s $12B opioid settlement offer
30 Aug 2019 //
FIERCE PHARMA
Endo, Allergan still on the hook after opioid deals: Ohio AG
24 Aug 2019 //
FIERCE PHARMA
Johnson & Johnson opioid trial judge expected to issue landmark verdict Monday
23 Aug 2019 //
CNBC
GSK submits its first application for daprodustat in Japan
22 Aug 2019 //
ENDPTS
Endo inks $10M opioid settlement as Allergan nears $5M deal
22 Aug 2019 //
FIERCE PHARMA
FDA Wins Court Case to Not Put Vasopressin on Compounding List
22 Aug 2019 //
RAPS